(lp0
S"Here's Why MannKind Corporation Remained Stuck in Reverse and Lost 24% in February Motley Fool - Mar 7, 2017 Shares of MannKind , a biopharmaceutical company primarily focused on the treatment of diabetes, plummeted 24% in February, according to data from S&amp;P Global Market Intelligence."
p1
aS"MannKind Corporation and Charles Mattocks Announce REVERSED-America's First ... GlobeNewswire  - Mar 8, 2017 VALENCIA, Calif. and TAMPA, Fla., March 08, 2017  -- MannKind Corporation and Bella &amp; Elle Media LLC announce MannKind's sponsorship of Reversed, a production series aimed at educating the show's participants and viewing&nbsp;..."
p2
aS'Why MannKind Corporation Stock Is Sinking Today Motley Fool - Mar 3, 2017 MannKind Corp.  is having yet another bad day today, with its stock falling 19% as of 11:30 a.m. EST on Friday.MannKind Corporation  Stock Sinks on Reverse Stock Split Plans - Investorplace.com'
p3
aS'MannKind - Afrezza Sales Struggle As February Comes To A Close Seeking Alpha - Mar 6, 2017 MannKind  investors hope that the third sales force pushing Afrezza is the charm, but the probabilities are stacked against them.'
p4
aS'Better Buy: MannKind Corp. vs. Dexcom Motley Fool - Mar 9, 2017 MannKind  and Dexcom  are two such businesses. Both companies have launched innovative products that are designed to make it far easier for patients to manage their disease.'
p5
aS"Analysts Near-Term outlook: 3D Systems Corporation , MannKind Corporation ... The USA Commerce - 19 hours ago Shares of 3D Systems Corporation  dropped -3.71% to $14.03. During the trading on 03/14/2017, Company's stock ranged from $13.93 to $14.56."
p6
aS"MannKind's  CEO Matt Pfeffer Presents At 29th Annual ROTH Conference ... Seeking Alpha - Mar 14, 2017 Okay. We are going to move onto our next presentation from MannKind Corporation. Ticker, MNKD. An approximately $200 million market cap company that is focused on drug delivery and treatments for diabetes."
p7
aS"Traders Targeted Mover: MannKind Corporation  Is stories - 54 minutes ago MannKind Corporation's  witnessed no change 0.00% in recent trading period with closing price of $ 2.02. The company's last traded volume of 0.86 million shares as compared to it's an average volume of 4.84 million shares.MannKind Corporation  earnings reaction history in focus - Post AnalystKeeping Tabs on Shares of MannKind Corporation  - SKV News"
p8
aS"Two Biotechs To Watch This Week: Novan, Inc.  and MannKind ... Market Exclusive - Mar 6, 2017 Last week we saw plenty of volatility across the healthcare and biotechnology sectors, driven both by macro and micro factors. We're expecting much of the same this week, and so as we kick off a fresh session, here are two companies that could really ..."
p9
aS'MannKind: Empty Saddles And Empty Promises Seeking Alpha - Feb 27, 2017 ... of 10%, where achieving this microscopic incremental revenue increase, MannKind  will need years and maybe decades before they could ever achieve a break-even point with revenues showing a profit for this floundering corporation.Shares of MannKind Corporation  Plunge -2.26% - Energy IndexIntraday Movers: MannKind Corporation  , Diageo plc  - NYSE Journal '
p10
a.